alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

112TH CONGRESS 

1ST SESSION H. R. 1371 

To amend SAFETEA–LU to ensure that projects that assist the establishment of aerotropolis transportation systems are eligible for certain 

grants, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 5, 2011 

Mr. COHEN introduced the following bill; which was referred to the Committee 

on Transportation and Infrastructure 

A BILL 

To amend SAFETEA–LU to ensure that projects that assist 

the establishment of aerotropolis transportation systems 

are eligible for certain grants, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Aerotropolis Act of 

5 2011’’. 


tjames on DSKG8SOYB1PROD with BILLS
2 

•HR 1371 IH

1 SEC. 2. PROJECTS OF NATIONAL AND REGIONAL SIGNIFI2 CANCE. 

3 (a) ELIGIBLE PROJECT DEFINED.—Section 

4 1301(c)(2) of SAFETEA–LU (23 U.S.C. 101 note) is 

5 amended to read as follows: 

6 ‘‘(2) ELIGIBLE PROJECT.— 

7 ‘‘(A) IN GENERAL.—The term ‘eligible 

8 project’ means any surface transportation 

9 project eligible for Federal assistance under 

10 title 23, United States Code, including freight 

11 railroad projects and activities eligible under 

12 such title. 

13 ‘‘(B) INCLUSION OF AEROTROPOLIS

14 TRANSPORTATION SYSTEM PROJECTS.—The 

15 term ‘eligible project’ includes a combination of 

16 projects described in subparagraph (A) that, as 

17 a group— 

18 ‘‘(i) assist the establishment of an 

19 aerotropolis transportation system; and 

20 ‘‘(ii) satisfy the requirement under 

21 subsection (d).’’. 

22 (b) AEROTROPOLIS TRANSPORTATION SYSTEM DE23 FINED.—Section 1301(c) of SAFETEA–LU (23 U.S.C. 

24 101 note) is amended by adding at the end the following: 

25 ‘‘(4) AEROTROPOLIS TRANSPORTATION SYS26 TEM.—The term ‘aerotropolis transportation system’ 


tjames on DSKG8SOYB1PROD with BILLS
3 

•HR 1371 IH

1 means a planned and coordinated multimodal freight 

2 and passenger transportation network that, as deter3 mined by the Secretary, provides efficient, cost-effec4 tive, sustainable, and intermodal connectivity to a 

5 defined region of economic significance centered 

6 around a major airport.’’. 

Æ 


tjames on DSKG8SOYB1PROD with BILLS
I 

112TH CONGRESS 

1ST SESSION H. R. 1509 

To amend title II of the Social Security Act to prohibit the inclusion of 

Social Security account numbers on Medicare cards. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 13, 2011 

Mr. SAM JOHNSON of Texas (for himself and Mr. DOGGETT) introduced the 

following bill; which was referred to the Committee on Ways and Means 

A BILL 

To amend title II of the Social Security Act to prohibit 

the inclusion of Social Security account numbers on 

Medicare cards. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Medicare Identity 

5 Theft Prevention Act of 2011’’. 

6 SEC. 2. PROHIBITION OF INCLUSION OF SOCIAL SECURITY 

7 ACCOUNT NUMBERS ON MEDICARE CARDS. 

8 (a) IN GENERAL.—Section 205(c)(2)(C) of the Social 

9 Security Act (42 U.S.C. 405(c)(2)(C)) is amended by add10 ing at the end the following new clause: 


rfrederick on DSKD9S0YB1PROD with BILLS
2 

•HR 1509 IH

1 ‘‘(xi) The Secretary of Health and Human Services, 

2 in consultation with the Commissioner of Social Security, 

3 shall establish cost-effective procedures to ensure that a 

4 Social Security account number (or any derivative thereof) 

5 is not displayed, coded, or embedded on the Medicare card 

6 issued to an individual who is entitled to benefits under 

7 part A of title XVIII or enrolled under part B of title 

8 XVIII and that any other identifier displayed on such card 

9 is easily identifiable as not being the Social Security ac10 count number (or a derivative thereof).’’. 

11 (b) EFFECTIVE DATE.— 

12 (1) IN GENERAL.—The amendment made by 

13 subsection (a) shall apply with respect to Medicare 

14 cards issued on and after an effective date specified 

15 by the Secretary of Health and Human Services, but 

16 in no case shall such effective date be later than the 

17 date that is 24 months after the date of the enact18 ment of this Act. 

19 (2) REISSUANCE.—In the case of individuals 

20 who have been issued such cards before such effec21 tive date, the Secretary of Health and Human Serv22 ices— 

23 (A) shall provide for the reissuance for 

24 such individuals of such a card that complies 


rfrederick on DSKD9S0YB1PROD with BILLS
3 

•HR 1509 IH

1 with such amendment not later than 3 years 

2 after such effective date; and 

3 (B) may permit such individuals to apply 

4 for the reissuance of such a card that complies 

5 with such amendment before the date of 

6 reissuance otherwise provided under subpara7 graph (A) in such exceptional circumstances as 

8 the Secretary may specify. 

Æ 


rfrederick on DSKD9S0YB1PROD with BILLS
**AD Economic Evaluation**



### Docket No
. **FAA -**  **2012 -**  **1206** Directorate ID : **2012 -**  **SW -**  **021 -** **AD** Helicopter Model: Sikorsky Model S
- 70, S
- 70A, and S
- 70C helicopters Number of Helicopters (U.S. Operators): 9 Helicopters in the US Registry
. Reason : The actions of this AD are intended to reduce or establish life limits to prevent fatigue failure of certain part s and subsequent loss of control of the helicopter. Costs : Parts per Helicopter $70,000 for the main rotor blade, $30,000 for the tail rotor blade, $490 for the el astomeric sleeve bearing, $233 for the right tie rod attach bolt, $40,000 for the main rotor hub, $12,000 for the main landing gear shock strut piston system, $44,000 for the tail rotor servo, $200 for the crossfeed breakaway valve, $59,000 for the main mo dule planetary carrier assembly, and $3,700 for the dowel pins (11 total). Labor per Helicopter ( 4.7 hour s x 

### $ 8 5 /work
-hour for replacement) $ 400.00 Other (Explain) Total US Fleet Cost $ 2,372,607 Executive Order 12866 : Could the AD be consider ed a “significant regulatory action?” Yes ( ) No (  ) DOT Regulatory Policies and Procedures : Is the AD significant? Yes ( ) Explain Below No (  ) Regulatory Flexibility Act : Will the AD have a significant economic impact on a substantial number of small entities? Yes ( ) No (  ) Project Engineer : Michael Davison
Exhibit 32(b)



AMERICANWEST BANCORPORATION



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002



I, C. Tim Cassels, state and attest that:



(1) I am the Chief Financial Officer of AmericanWest Bancorporation (the
Registrant).



(2) I hereby certify, pursuant to 18 U.S. C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that



| |  | the Annual Report on Form 10-K of the Registrant for the year ended December 31, 2003 (the periodic report) containing financial statements fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78 o(d)); and
| | - | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  | the information contained in the periodic report fairly presents, in all material respects, the financial condition and results of operations of the Registrant for the periods
presented.
| | - | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|      |  |                                                     
|----- |  | ----------------------------------------------------
|Name: |  | /s/ C. Tim Cassels                                  
|Title |  | Executive Vice President and Chief Financial Officer
|Date: |  | March 8, 2004
Order entered February 24, 2020

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-19-00874-CV

MELINDA MORA, Appellant

V.

CHARLES WINE, ET AL., Appellees

On Appeal from the County Court at Law No. 5

Dallas County, Texas

Trial Court Cause No. CC-16-05690-E

ORDER

Before the Court is appellant’s February 19, 2020 motion to supplement the clerk’s 

record. We GRANT the motion. We ORDER John Warren, Dallas County Clerk, to file, by 

February 28, 2020, a supplemental clerk’s record containing:

Plaintiff’s Response to Defendant’s No-Evidence Motion for Summary Judgment – filed 

on May 11, 2018.

We DIRECT the Clerk of this Court to send a copy of this order to Mr. Warren and all 

parties.

/s/ ROBERT D. BURNS, III

CHIEF JUSTICE
Exhibit 99.1

                         Merchants Bancshares, Inc.

                              275 Kennedy Drive
                         South Burlington, VT  05403

             LETTER TO COMMISSION PURSUANT TO TEMPORARY NOTE 3T

                               March 25, 2002


Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549-0408

Ladies and Gentlemen:

Pursuant to Temporary Note 3T to Article 3 of Regulation S-X, Merchants
Bancshares, Inc. has obtained a letter of representation from Arthur
Andersen LLP ("Andersen") stating that the December 31, 2001 audit was
subject to their quality control system for the U.S. accounting and
auditing practice to provide reasonable assurance that the engagement was
conducted in compliance with professional standards, that there was
appropriate continuity of Andersen personnel working on the audit and
availability of national office consultation. Availability of personnel at
foreign affiliates of Andersen is not relevant to this audit.

                                       Very truly yours,

                                       Merchants Bancshares, Inc.

                                       /s/ Janet Spitler

                                       Janet Spitler
                                       Treasurer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Integration of Novel Measures for Improved Classification of Type 2 Diabetes Consortium Review.                    

*Date:*                         March 19, 2024.                    

*Time:*                         10:30 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate cooperative agreement applications.                    

*Place:*                         National Institutes of Health, NIDDK Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Ann A. Jerkins, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-594-2242,                         *jerkinsa@niddk.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: February 12, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-03211 Filed 2-15-24; 8:45 am]

BILLING CODE 4140-01-P
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

EL PASO TOOL AND DIE

COMPANY, INC.

, §

No. 08

- 19

- 00 087

- CV

Appellant, §

Appeal from the

v. §

County Court at Law Number Three

§

CARLOS MENDEZ of El Paso County, Texas

§

Appellee. (TC# 2017

- DCV0027 )

§

J U D G M E N T

The Court has considered this cause on the record and concludes that the petition for

permissive review was improvidently granted. We therefore remand the cause to the trial court

in accordance with this Court = s opinion. We further order that Appell ee recover from Appell ant

all costs of this appeal, for which let execution issue. This decision shall be certified below for

observan ce.

IT IS SO ORDERED THIS 4 TH DAY OF DECEMBER , 201 9

.

JEFF ALLEY, Chief Justice

Before Alley, C.J., Rodriguez, and Palafox, JJ.

Alley, C.J., Concurring
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                  1
<CURRENCY>                    U.S. DOLLARS
       
<S>                           <C>
<PERIOD-TYPE>                 12-MOS
<FISCAL-YEAR-END>             DEC-31-1995               
<PERIOD-START>                JAN-01-1995
<PERIOD-END>                  DEC-31-1995
<EXCHANGE-RATE>               1    
<CASH>                            609,466
<SECURITIES>                            0
<RECEIVABLES>                     479,688
<ALLOWANCES>                       15,000
<INVENTORY>                       963,904
<CURRENT-ASSETS>                2,205,412
<PP&E>                          1,779,337
<DEPRECIATION>                    580,875
<TOTAL-ASSETS>                  3,451,426
<CURRENT-LIABILITIES>             313,578
<BONDS>                                 0
<PREFERRED-MANDATORY>                   0
<PREFERRED>                             0
<COMMON>                           16,366           
<OTHER-SE>                      2,075,157
<TOTAL-LIABILITY-AND-EQUITY>    3,451,426            
<SALES>                         3,758,953
<TOTAL-REVENUES>                3,758,953
<CGS>                           1,683,678
<TOTAL-COSTS>                   1,683,678
<OTHER-EXPENSES>                1,925,149
<LOSS-PROVISION>                        0
<INTEREST-EXPENSE>                115,081
<INCOME-PRETAX>                   103,592
<INCOME-TAX>                        2,000
<INCOME-CONTINUING>               101,592
<DISCONTINUED>                          0
<EXTRAORDINARY>                         0
<CHANGES>                               0
<NET-INCOME>                      101,592
<EPS-PRIMARY>                         .07
<EPS-DILUTED>                         .07 
        


</TABLE>
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1487 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 1487

To amend the Federal Food, Drug, and Cosmetic Act to ban the use of the 
        arsenic compound known as roxarsone as a food additive.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 12, 2011

  Mr. Israel introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
To amend the Federal Food, Drug, and Cosmetic Act to ban the use of the 
        arsenic compound known as roxarsone as a food additive.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Poison-Free Poultry Act of 2011''.

SEC. 2. BAN ON USE OF ARSENIC COMPOUND KNOWN AS ROXARSONE AS FOOD 
              ADDITIVE.

    (a) Ban.--Section 409 of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 348) is amended by adding at the end the following:
    ``(k) Ban on Use of Arsenic Compound Roxarsone.--The arsenic 
compound known as roxarsone--
            ``(1) shall not be subject to section 201(s)(4); and
            ``(2) is deemed to be an unsafe food additive within the 
        meaning of this section.''.
    (b) Effective Date.--The amendment made by this section shall take 
effect one year after the date of the enactment of this Act.
                                 <all>
```
---

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Eddie Chou, Chief Financial Officer, of
Biopack Environmental Solutions Inc. (the Company), hereby certifies, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

|(1) | the Quarterly Report on Form 10-QSB/A of the Company for
      the fiscal quarter ended September 30, 2007 (the "Report") fully complies
      with the requirements of Section 13(a) or 15(d) of the Securities Exchange
      Act of 1934; and
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                                                                                                                 
|(2) | the information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.                                                                                

Dated: March 25, 2008

|/s/ Eddie Chou                                   | 
|------------------------------------------------ | 
|Eddie Chou                                       | 
|Chief Financial Officer                          | 
|(Principal Financial Officer and
      Principal | 
|Accounting Officer)                              | 

A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Biopack
Environmental Solutions Inc. and will be retained by Biopack Environmental
Solutions Inc. and furnished to the Securities and Exchange Commission or its
staff upon request.

---
EXHIBIT 32.2








SECTION 1350 CERTIFICATIONS





In connection with the Annual Report of Security Capital Corporation (the “Company”) on Form 10-K for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Connie Hawkins, Chief Financial Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that:





1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date:           March 15, 2011








/s/ Connie Hawkins


Connie Hawkins


Chief Financial Officer
**EXHIBIT 32**

 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

 

 

In connection with the Quarterly Report of YFC 355 Corp. (the “Company”) on Form 10-QSB for the period ended June 30, 2005, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Anthony N. DeMint, President and Chief Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|----|-----------------------------------------------------------------------------------------------------------------------|

 

| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------|

 

 

 

| /s/ Anthony DeMint |
|--------------------|

Anthony N. DeMint

President and Chief Accounting Officer

August 10, 2005
Exhibit 32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with this quarterly report on Form 10-Q for the quarter ended December 31, 2010 (the Report) of OPNET
Technologies, Inc. (the Company), I, Marc A. Cohen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  |  |  |     |  |                                     
|----------------------- |  |  |  | --- |  | ------------------------------------
|Dated: February 4, 2011 |  |  |  | By: |  | /S/    MARC
A. COHEN                
|                        |  |  |  |     |  | Marc A. Cohen                       
|                        |  |  |  |     |  | Chairman and Chief Executive Officer
#### Herbert B. MARTIN, Appellant, v. The STATE *of*Texas, Appellee.

No. 28517.

Court of Criminal Appeals of Texas.

Oct. 31, 1956.

No attorney for appellant of record on appeal.

Leon B. Douglas, State’s Atty., Austin, for the State.

WOODLEY, Judge.

The conviction is for possession of marihuana, on a plea of guilty before the court; the punishment, three years.

No statement of facts is found in the record and no bills of exception.

In pronouncing sentence the trial cotirt failed to give application to the indeterminate sentence statute, art. 775, Vernon’s Ann.C.C.P.

The sentence is reformed so as to order appellant’s confinement in the penitentiary for not less than two years nor more than three years.

As reformed, the judgment is affirmed.